Please sign in to follow a disease.
vTv Therapeutics
Clinical trials sponsored by vTv Therapeutics, explained in plain language.
A clinical-stage biopharmaceutical company developing treatments for metabolic and inflammatory diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill aims to slash severe hypoglycemia in type 1 diabetes Results expected Apr 2027 (estimated) May already have reported ↗
- New pill may boost insulin pump performance in type 1 diabetes Results expected Jun 2027 (estimated)